Insulin Icodec Dose Calculation from Glargine 36 Units Daily
For a patient taking insulin glargine 36 units per day, the initial weekly insulin icodec dose should be 378 units (36 units × 7 × 1.5), rounded to 380 units, which includes a mandatory 50% one-time additional loading dose for the first injection only. 1
Dosing Algorithm for Switching from Daily Basal Insulin to Icodec
First Injection (Week 1)
- Calculate base weekly dose: Daily glargine dose × 7 = 36 × 7 = 252 units
- Add 50% loading dose: 252 × 1.5 = 378 units
- Round to nearest 10 units: 380 units for first injection 1
The 50% one-time additional dose is recommended when switching from daily basal insulin to prevent transient hyperglycemia during the 2-4 weeks needed to reach steady state 1. This loading dose approach reduces fasting plasma glucose elevation and time above range in the first 4 weeks compared to initiating without additional dosing 1.
Second Injection Onward (Week 2+)
- Use base weekly dose only: 36 × 7 = 252 units, rounded to 250 units
- No additional loading dose after first injection 1
The icodec pen adjusts in 10-unit increments, so all doses should be rounded to the nearest 10 units 1.
Important Clinical Considerations
Monitoring Requirements
- Measure prebreakfast self-monitored blood glucose (SMBG) three times weekly: 2 days prior to and on the day of each weekly injection 1
- Continuous glucose monitoring (CGM) is strongly recommended during the initial transition period to detect both hyperglycemia and hypoglycemia 1
- Increase monitoring frequency during the first 2-4 weeks as steady state is achieved 1
Titration After Initiation
Weekly dose adjustments should be based on the three prebreakfast SMBG values:
- If any value is below target range: Titrate based on the lowest recorded value
- If all values are above target range: Titrate based on the mean of the three measurements
- Target prebreakfast glucose: 80-130 mg/dL (4.4-7.2 mmol/L) 1
Special Population Adjustments
For this specific patient on 36 units daily, no dose reduction is typically needed unless:
- Low BMI or chronic kidney disease: Consider starting at 50% of calculated dose (approximately 180-190 units for first injection) 1
- Elderly patients or those with hepatic/renal impairment: May titrate less aggressively but can use standard starting dose 1
- History of severe hypoglycemia or hypoglycemia unawareness: Exercise caution and consider more conservative dosing 1
Hypoglycemia Risk
The ONWARDS 2 trial, which specifically studied patients switching from daily basal insulin (similar to this clinical scenario), showed comparable hypoglycemia rates between icodec and degludec 1. However, the 50% loading dose does not increase hypoglycemia risk compared to the base dose alone 1. Clinical steady state is reached 2-3 weeks after initiation with the loading dose versus 2-4 weeks without it 1.
Concomitant Medications
- Continue other non-insulin glucose-lowering medications
- Reduce or discontinue insulin secretagogues (sulfonylureas, meglitinides) to minimize hypoglycemia risk 1
- No dose adjustment needed for renal or hepatic impairment per FDA labeling 2
Key Pitfalls to Avoid
- Do not repeat the 50% loading dose: Only the first injection receives the additional dose; subsequent injections use the base weekly calculation 1
- Do not underdose: The full 1.5× multiplier for week 1 is important to prevent transient hyperglycemia during the loading phase 1
- Ensure proper patient education: Clear instructions are critical to prevent accidental overdosing or confusion about the one-time loading dose 1
- Do not mix or dilute: Icodec must be administered alone, not mixed with other insulins 2